Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Fish and Richardson
Cerilliant
Moodys
Teva
Baxter
Deloitte
Julphar
Chinese Patent Office

Generated: September 20, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: CLORAZEPATE DIPOTASSIUM

« Back to Dashboard

CLORAZEPATE DIPOTASSIUM

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Recordati Rare TRANXENE clorazepate dipotassium CAPSULE;ORAL 017105 NDA RECORDATI RARE DISEASES, INC. 55292-304-01 100 TABLET in 1 BOTTLE (55292-304-01)
Mylan CLORAZEPATE DIPOTASSIUM clorazepate dipotassium TABLET;ORAL 071858 ANDA Mylan Pharmaceuticals Inc. 0378-0030-01 100 TABLET in 1 BOTTLE, PLASTIC (0378-0030-01)
Mylan CLORAZEPATE DIPOTASSIUM clorazepate dipotassium TABLET;ORAL 071858 ANDA Mylan Pharmaceuticals Inc. 0378-0030-05 500 TABLET in 1 BOTTLE, PLASTIC (0378-0030-05)
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Moodys
Queensland Health
Mallinckrodt
McKinsey
Baxter
Chinese Patent Office
Merck
US Department of Justice